Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 18, Issue 3, 2013, Pages 270-279

  Dai, Wangde ^a   Gerczuk, Paul ^a   Zhang, Yuanyuan ^b   Smith, Leona ^b   Kopyov, Oleg ^c   Kay, Gregory L ^a   Jyrala, Aarne J ^a   Kloner, Robert A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Celavie Biosciences   (United States)

Author keywords

Heart tissue derived extracellular matrix; Myocardial infarction

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; FEMALE; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL; HEART VENTRICULOGRAPHY; IMPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; CORONARY VESSELS; EXTRACELLULAR MATRIX; FEMALE; HEART VENTRICLES; INJECTIONS, INTRALESIONAL; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PARTICLE SIZE; PROTO-ONCOGENE PROTEINS C-KIT; RATS; RATS, INBRED F344; STEM CELLS; STROKE VOLUME; TISSUE EXTRACTS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84879248779     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248412472257     Document Type: Article

References (32)

1. Morita M, Eckert CE, Matsuzaki K, et al. Modification of infarct material properties limits adverse ventricular remodeling. Ann Thorac Surg. 2011;92(2):617-624.
2. Tous E, Ifkovits JL, Koomalsingh KJ, et al. Influence of injectable hyaluronic acid hydrogel degradation behavior on infarctioninduced ventricular remodeling. Biomacromolecules. 2011;12(11): 4127-4135.
3. Zhao ZQ, Puskas JD, Xu D, et al. Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction. J Am Coll Cardiol. 2010;55(12): 1250-1261.
4. Seif-Naraghi SB, Salvatore MA, Schup-Magoffin PJ, Hu DP, Christman KL. Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering. Tissue Eng Part A. 2010;16(6):2017-2027.
5. Singelyn JM, DeQuach JA, Seif-Naraghi SB, Littlefield RB, Schup-Magoffin PJ, Christman KL. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials. 2009;30(29):5409-5416.
6. Singelyn JM, Christman KL. Modulation of material properties of a decellularized myocardial matrix scaffold. Macromol Biosci. 2011;11(6):731-738.
7. Singelyn JM, Sundaramurthy P, Johnson TD, et al. Catheterdeliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J Am Coll Cardiol. 2012;59(8):751-763.
8. Zhang Y, He Y, Bharadwaj S, et al. Tissue-specific extracellular matrix coatings for the promotion of cell proliferation and maintenance of cell phenotypes. Biomaterials. 2009;30(23-24): 4021-4028.
9. Liu Y, Bharadwaj S, Lee SJ, Atala A, Zhang Y. Optimization of a natural collagen scaffold to aid cell-matrix penetration for urologic tissue engineering. Biomaterials. 2009;30(23-24):3865-3873.
10. Lang R, Stern M, Leona SL, et al. 3D liver ECM for human hepatocyte growth and differentiation. Biomaterials. 2011; 32(29):7042-7052.
11. Skardal A, Smith L, Bharadwaj S, Soker S, Atala A, Zhang Y. Tissue specific synthetic ECM hydrogels for in vitro maintenance of hepatocyte function. Biomaterials. 2012;33(18):4565-4575.
12. Dai W, Kloner RA. Experimental cell transplantation therapy in rat myocardial infarction model including nude rat preparation. Methods Mol Biol. 2010;660:99-109.
13. Yao M, Dieterle T, Hale SL, et al. Long-term outcome of fetal cell transplantation on postinfarction ventricular remodeling and function. J Mol Cell Cardiol. 2003;35(6):661-670.
14. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation. 1987;75(1):299-306.
15. Dai W, Kay GL, Jyrala AJ, Kloner RA. Experience from experimental cell transplantation therapy of myocardial infarction: what have we learned? Cell Transplant. 2012. doi: 10.3727/ 096368911X627570.
16. Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 2004;10(3-4): 403-409.
17. Dai W, Wold LE, Dow JS, Kloner RA. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol. 2005;46(4): 714-719.
18. Tsur-Gang O, Ruvinov E, Landa N, et al. The effects of peptidebased modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials. 2009;30(2): 189-195.
19. Lin YD, Yeh ML, Yang YJ, et al. Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs. Circulation. 2010;122(suppl 11):S132-S141.
20. Cheng K, Malliaras K, Shen D, et al. Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction. J Am Coll Cardiol. 2012;59(3):256-264.
21. Davis ME, Motion JP, Narmoneva DA, et al. Injectable selfassembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation. 2005;111(4):442-450.
22. Huang NF, Yu J, Sievers R, Li S, Lee RJ. Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng. 2005;11(11-12):1860-1866.
23. Dai W, Kay GL, Jyrala AJ, Kloner RA. Direct collagen injection to thicken the infarct scar: collagen density determines angiogenesis (abstract). J Am Coll Cardiol. 2007;49(9) (suppl A):185 A.
24. Dai W, Kloner RA. Potential therapeutic application of injectable biomaterials in cardiac repair. Int Circ. 2007;5:8-9.
25. Bearzi C, Rota M, Hosoda T, et al. Human cardiac stem cells. Proc Natl Acad Sci U S A. 2007;104(35):14068-14073.
26. Hatzistergos KE, Quevedo H, Oskouei BN, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res. 2010;107(7):913-922.
27. Ou L, Li W, Zhang Y, et al. Intracardiac injection of matrigel induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J Cell Mol Med. 2011;15(6): 1310-1318.
28. Akaishi M, Weintraub WS, Schneider RM, Klein LW, Agarwal JB, Helfant RH. Analysis of systolic bulging. Mechanical characteristics of acutely ischemic myocardium in the conscious dog. Circ Res. 1986;58(2):209-217.
29. Jensen-Urstad K, Bouvier F, Hojer J, et al. Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy. Am J Cardiol. 1998;81(5):538-544.
30. Visser CA, Kan G, Meltzer RS, Koolen JJ, Dunning AJ. Incidence, timing and prognostic value of left ventricular aneurysm formation after myocardial infarction: a prospective, serial echocardiographic study of 158 patients. Am J Cardiol. 1986;57(10):729-732.
31. Wall ST, Walker JC, Healy KE, Ratcliffe MB, Guccione JM. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation. 2006; 114(24):2627-2635.
32. Rane AA, Chuang JS, Shah A, et al. Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction. PLoS One. 2011;6(6):e21571. Biosciences